Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma: Final Analysis of KEYNOTE-170

Medicine, Neutropenia, Refractory (planetary science), Internal medicine, Adverse effect, Surgery, Lymphoma, Alemtuzumab, Rituximab, Transplantation, Phases of clinical research, Gastroenterology, Chemotherapy